Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Hoth Therapeutics initiates confirmatory study of the AEA-loaded-Z pods in models of lupus

Nov. 7, 2019

Further interim data presented from phase Ib study of EDP-1815 in patients with psoriasis

Nov. 6, 2019

Clinical development of MOR-106 for atopic dermatitis ended for futility

Oct. 29, 2019

BioCryst Pharmaceuticals discloses complement factor D inhibitors

Oct. 29, 2019

Microbion announces phase Ib data for pravibismane in infected diabetic foot ulcers

Oct. 29, 2019

First subject dosed in phase II ADVISE study of etrasimod in atopic dermatitis

Oct. 29, 2019

Arcutis plans phase III program with ARQ-151 for plaque psoriasis

Oct. 28, 2019

Rapt Therapeutics studies oral CCR4 antagonist RPT-193 in first-in-human trial

Oct. 24, 2019

Ex vivo gene-corrected autologous cell therapy for chronic RDEB wounds: results of phase I/IIa trial

Oct. 24, 2019

FDA grants approval to Amzeeq topical foam for acne

Oct. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...